Rates and Predictors of Treatment With Oral Anticoagulant in Patients Newly Diagnosed With Atrial Fibrillation at High-Risk for Stroke

被引:0
|
作者
Manning, Evan
Burns, Kelley
Laurie, Melissa
Luke, Patten
Ho, Michael
Sandhu, Amneet
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A13015
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleed
    Crivera, Concetta
    Nelson, Winnie W.
    Schein, Jeff R.
    Witt, Edward A.
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 795 - 805
  • [42] Potential omissions of oral anticoagulant among older US adults with newly diagnosed atrial fibrillation
    Jiron, Marcela
    Pate, Virginia
    Hanson, Laura C.
    Lund, Jennifer
    Funk, Michele Jonsson
    Sturmer, Til
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 292 - 292
  • [43] Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding
    Saghar Niaz
    Chris Kirwan
    Natasha Clayton
    Mathew Mercuri
    Kerstin de Wit
    Canadian Journal of Emergency Medicine, 2021, 23 : 325 - 329
  • [44] Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding
    Niaz, Saghar
    Kirwan, Chris
    Clayton, Natasha
    Mercuri, Mathew
    de Wit, Kerstin
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2021, 23 (03) : 325 - 329
  • [45] The effectiveness of atrial fibrillation special clinic on oral anticoagulant use for high risk atrial fibrillation patients managed in the community
    Lau, Ka Man
    Leung, To Fung
    Li, Yim Chu
    Chen, Catherine Xiao Rui
    BMC PRIMARY CARE, 2023, 24 (01):
  • [46] Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
    Hsu, Jin-Yi
    Liu, Peter Pin-Sung
    Sposato, Luciano A.
    Huang, Huei-Kai
    Liu, An-Bang
    Lai, Edward Chia-Cheng
    Lin, Swu-Jane
    Hsieh, Cheng-Yang
    Loh, Ching-Hui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [47] PREDICTORS OF ASPIRIN VERSUS ORAL ANTICOAGULANT PRESCRIPTION IN ATRIAL FIBRILLATION PATIENTS AT-RISK FOR STROKE: INSIGHTS FROM THE NCDR® PINACLE REGISTRY
    Hsu, Jonathan
    Maddox, Thomas
    Kennedy, Kevin
    Katz, David
    Marzec, Lucas
    Gehi, Anil
    Turakhia, Mintu
    Marcus, Gregory
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A420 - A420
  • [48] The effectiveness of atrial fibrillation special clinic on oral anticoagulant use for high risk atrial fibrillation patients managed in the community
    Ka Man Lau
    To Fung Leung
    Yim Chu Li
    Catherine Xiao Rui Chen
    BMC Primary Care, 24
  • [49] Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke
    Kim, J. -M.
    Park, K. -Y.
    Yu, I. -W.
    Song, T. -J.
    Kim, Y. -J.
    Kim, B. J.
    Heo, S. H.
    Jung, J. -M.
    Oh, K. -M.
    Kim, C. K.
    Yu, S.
    Park, J. -H.
    Choi, J. C.
    Park, M. -S.
    Kim, J. -T.
    Choi, K. -H.
    Hwang, Y. -H.
    Chung, J. -W.
    Bang, O. Y.
    Kim, G. -M.
    Seo, W. -K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (05) : 900 - 902
  • [50] Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
    Turpie, Alexander G. G.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 197 - 205